Skip to main content
David Straus, MD, Hematology, New York, NY

DavidJStrausMD

Hematology New York, NY

Hematologic Oncology

Professor of Clinical Medicine, Weill Cornell Medical College

Dr. Straus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Straus' full profile

Already have an account?

  • Office

    525 East 72nd Street
    18G
    New York, NY 10021
    Phone+1 646-207-0455

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1975 - 1977
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1972 - 1973
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1969 - 1972
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 1969

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1974 - Present
  • FL State Medical License
    FL State Medical License 2022 - Present
  • NY State Medical License
    NY State Medical License 1970 - 2025
  • NJ State Medical License
    NJ State Medical License Active through 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Top Cancer Docters Newsweek, 2015
  • Top Doctors Castle Connolly, 2015
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma Based on Interim PET  
    David J Straus, Heiko Schoder, Bruce D Cheson, John C Grecula, Lale Kostakoglu, Eric D Hsi, Leslie L Popplewell, John P Leonard, Craig H Moskowitz, Brad S Kahl, Jonath..., Blood

Abstracts/Posters

  • Genomic Profiling of Mantle Cell Lymphoma Suggests Poor-Risk Profile Is Present at Diagnosis and Does Not Arise By Tumor Evolution
    David J. Straus, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Long-Term Follow-up Confirms Durability of Single-Agent Brentuximab Vedotin As Pre-Transplant Salvage for Classical Hodgkin Lymphoma
    David J. Straus, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of ...
    David J. Straus, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Brentuximab vedotin with chemotherapy for stage 3/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Brentuximab Vedotin with Chemotherapy in Adolescents and Young Adults (AYA) with Stage III or IV Hodgkin Lymphoma: A Subgroup Analysis from the Phase 3 Echelon-1 Study 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Improving outcomes with brentuximab vedotin (BV) plus chemotherapy in patients with newly diagnosed advanced stage Hodgkin lymphoma. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018